Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.10 HKD
Change Today +0.04 / 0.57%
Volume 17.8M
1093 On Other Exchanges
Hong Kong
As of 4:01 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

cspc pharmaceutical group lt (1093) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/17/15 - $8.57
52 Week Low
02/11/15 - $5.81
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CSPC PHARMACEUTICAL GROUP LT (1093)

Related News

No related news articles were found.

cspc pharmaceutical group lt (1093) Related Businessweek News

No Related Businessweek News Found

cspc pharmaceutical group lt (1093) Details

CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products. It offers finished drugs, including NBP series primarily for the acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning principally for hypertension; Duomeisu, a chemotherapy drug for the treatment of lymphoma, multiple myeloma, and ovarian and breast cancer; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; and Ailineng primarily for the treatment of nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion. The company also provides generic drugs, antibiotics, vitamin C products, and caffeine and other drugs; and products, such as benzylpenicillin sodium, ampicillin sodium, cefazolin sodium, cafradin, ceftriaxone, cefotaxime sodium, cefoperazone sodium, amoxicillin capsule, amoxicillin dispersible tablet, amoxicillin granule, etc. In addition, it has 170 products under research and development with focus on the therapeutic areas of cardio-cerebrovascular, diabetes, oncology, neurology, and anti-infective. Further, the company is involved in the provision of pharmaceutical research and development services; sewage and pharmaceutical by-products treatment activities; and trading of pharmaceutical products. It has operations in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was founded in 1997 and is based in Wan Chai, Hong Kong.

10,565 Employees
Last Reported Date: 04/17/15
Founded in 1997

cspc pharmaceutical group lt (1093) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: $4.4M
Executive Director
Total Annual Compensation: $2.0M
Executive Director
Total Annual Compensation: $798.0K
Executive Director
Total Annual Compensation: $798.0K
Executive Director
Total Annual Compensation: $798.0K
Compensation as of Fiscal Year 2014.

cspc pharmaceutical group lt (1093) Key Developments

CSPC Pharmaceutical Group Limited Announces Retirement of Zhao John Huan as Executive Director

The board of directors of CSPC Pharmaceutical Group Limited announced that Mr. Zhao John Huan, an executive director of the company, retired from office as executive director of the company at the conclusion of the annual general meeting of the company held on 26 May 2015. Mr. ZHAO did not offer himself for re-election at the AGM due to work related reasons.

CSPC Pharmaceutical Group Limited Approves New Articles of Association

CSPC Pharmaceutical Group Limited announced at its annual general meeting held on May 26, 2015, approved the adoption of new articles of association of the company.

CSPC Pharmaceutical Group Limited Declares Final Dividend for the Year Ended December 31, 2014

CSPC Pharmaceutical Group Limited announced that at the AGM held on May 26, 2015, the shareholders declared final dividend of 10 Hong Kong cents per share for the year ended December 31, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1093:HK $7.10 HKD +0.04

1093 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1093.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1093 Industry Range
Price/Earnings 29.9x
Price/Sales 3.7x
Price/Book 5.2x
Price/Cash Flow 29.6x
TEV/Sales 3.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSPC PHARMACEUTICAL GROUP LT, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at